News Announcement

Aurobindo Pharma: Entry Into Marketing And Distribution Agreement For Biosimilars In EU Territories By Curateq Biologics Private Limited

Intimation of entry into marketing and distribution agreement for Biosimilars in EU territories by Curateq Biologics Private Limited a wholly owned subsidiary of the Company.

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.